IFP Advisors’s Pacira BioSciences PCRX Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $21.6K | Sell |
446
-226
| -34% | -$10.9K | ﹤0.01% | 2513 |
|
2025
Q1 | $16.7K | Hold |
672
| – | – | ﹤0.01% | 2367 |
|
2024
Q4 | $12.7K | Buy |
672
+2
| +0.3% | +$38 | ﹤0.01% | 2443 |
|
2024
Q3 | $10.1K | Hold |
670
| – | – | ﹤0.01% | 2424 |
|
2024
Q2 | $19.2K | Hold |
670
| – | – | ﹤0.01% | 2107 |
|
2024
Q1 | $19.6K | Sell |
670
-50
| -7% | -$1.46K | ﹤0.01% | 1979 |
|
2023
Q4 | $24.3K | Buy |
720
+25
| +4% | +$844 | ﹤0.01% | 1838 |
|
2023
Q3 | $21.3K | Hold |
695
| – | – | ﹤0.01% | 1918 |
|
2023
Q2 | $27.8K | Hold |
695
| – | – | ﹤0.01% | 1857 |
|
2023
Q1 | $23.6K | Sell |
695
-41
| -6% | -$1.39K | ﹤0.01% | 1943 |
|
2022
Q4 | $26K | Sell |
736
-192
| -21% | -$6.78K | ﹤0.01% | 2694 |
|
2022
Q3 | $36K | Buy |
928
+11
| +1% | +$427 | ﹤0.01% | 2640 |
|
2022
Q2 | $36K | Hold |
917
| – | – | ﹤0.01% | 2402 |
|
2022
Q1 | $36K | Buy |
917
+222
| +32% | +$8.72K | ﹤0.01% | 2402 |
|
2021
Q4 | $42K | Hold |
695
| – | – | ﹤0.01% | 1594 |
|
2021
Q3 | $39K | Buy |
695
+670
| +2,680% | +$37.6K | ﹤0.01% | 1631 |
|
2021
Q2 | $2K | Hold |
25
| – | – | ﹤0.01% | 2741 |
|
2021
Q1 | $2K | Sell |
25
-126
| -83% | -$10.1K | ﹤0.01% | 2665 |
|
2020
Q4 | $9K | Sell |
151
-1,207
| -89% | -$71.9K | ﹤0.01% | 2102 |
|
2020
Q3 | $81K | Buy |
+1,358
| New | +$81K | ﹤0.01% | 1089 |
|
2020
Q2 | – | Hold |
0
| – | – | – | 3440 |
|
2019
Q1 | – | Sell |
-200
| Closed | -$9K | – | 3091 |
|
2018
Q4 | $9K | Buy |
+200
| New | +$9K | ﹤0.01% | 2527 |
|
2017
Q1 | – | Sell |
-100
| Closed | -$3K | – | 4052 |
|
2016
Q4 | $3K | Hold |
100
| – | – | ﹤0.01% | 3503 |
|
2016
Q3 | $3K | Sell |
100
-11
| -10% | -$330 | ﹤0.01% | 3453 |
|
2016
Q2 | $4K | Buy |
+111
| New | +$4K | ﹤0.01% | 3246 |
|
2016
Q1 | – | Sell |
-100
| Closed | -$8K | – | 3111 |
|
2015
Q4 | $8K | Buy |
+100
| New | +$8K | ﹤0.01% | 2685 |
|